ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 87 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q2 2018. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $215,000 | +18.8% | 42,000 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $181,000 | -13.4% | 42,000 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $209,000 | -2.8% | 42,000 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $215,000 | -39.4% | 42,000 | -52.8% | 0.00% | -50.0% |
| Q2 2019 | $355,000 | +34.0% | 89,000 | +263.3% | 0.00% | 0.0% |
| Q1 2019 | $265,000 | +22.7% | 24,500 | -44.9% | 0.00% | +100.0% |
| Q4 2018 | $216,000 | -18.5% | 44,500 | +81.6% | 0.00% | -50.0% |
| Q3 2018 | $265,000 | -9.9% | 24,500 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $294,000 | +14.4% | 24,500 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $257,000 | – | 24,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 6,287,101 | $4,903,939 | 2.63% |
| Syncona Portfolio Ltd | 1,377,294 | $1,074,289 | 1.60% |
| MPM BioImpact LLC | 5,095,912 | $3,974,811 | 1.06% |
| NEA Management Company, LLC | 17,079,778 | $13,322,227 | 1.03% |
| TANG CAPITAL MANAGEMENT LLC | 5,166,954 | $4,030,224 | 0.57% |
| PFM Health Sciences, LP | 10,423,135 | $8,130,045 | 0.38% |
| Matrix Capital Management Company, LP | 38,974,185 | $30,399,864 | 0.36% |
| Long Focus Capital Management, LLC | 10,963,158 | $8,551,263 | 0.31% |
| Acuitas Investments, LLC | 479,764 | $374,216 | 0.22% |
| Endurant Capital Management LP | 311,944 | $243,316 | 0.22% |